Aurigene Oncology gets positive results of Phase 1 study for CAR-T cell therapy for multiple myeloma
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
USFDA completes PAI of Lupin’s biotech facility in Pune
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Subscribe To Our Newsletter & Stay Updated